Biotech news for Tuesday, June 16, 2026, ranked by our 5-dimension investment framework — regulatory, technology, commercial, manufacturing, and narrative.
Shares of Mirum Pharmaceuticals ( MIRM ) and Incyte ( INCY ) are in focus after the companies delivered positive pivotal Phase 2 data for their oral FOP candidate, zilurgisertib. Results from Cohort 1 of the PROGRESS study demonstrated a consistent treatment e…
fengdr Here's a list of key deals reported across sectors this week: Roku Inc. ( ROKU ) soared 20% on a report that the streaming video platform is in discussions to sell itself. Barclays ( BCS ) to acquire children's debit card and money management
Hailshadow Johnson & Johnson ( JNJ ) announced on Saturday that its bispecific T-cell engager Talvey, when used with Halozyme ( HALO )-partnered Darzalex Faspro, reduced the risk of death by up to 53% compared to standard treatment in a late-stage trial fo…
kemalbas/iStock via Getty Images CMS is floating a proposal that would create a permanent framework for Medicare drug price negotiations. Under the plan, the agency will choose up to 20 more drugs covered under Part D and/or payable under Part B for what would
XOMA Corp - 8.375% DP PFD B ( XOMAO ) declares $0.5234/share quarterly dividend . Forward yield 8.24% Payable July 15; for shareholders of record July 2; ex-div July 2. See XOMAO Dividend Scorecard, Yield Chart, & Dividend Growth. More on XOMA XOMA Royalty…
XOMA Preferred Shares Series A ( XOMAP ) declares $0.539/share quarterly dividend , in line with previous. Forward yield 8.47% Payable July 15; for shareholders of record July 2; ex-div July 2. See XOMAP Dividend Scorecard, Yield Chart, & Dividend Growth.…
spawns Shares of Summit Therapeutics ( SMMT ) bounced back, recovering recent losses on Friday after the cancer drug developer’s co-CEO Robert Duggan disclosed the purchase of nearly $50M worth of company shares. According to a regulatory filing on Friday, Dug…
georgeclerk ORIC Pharmaceuticals ( ORIC ) traded higher on Friday after Stifel resumed its coverage with a Buy recommendation, citing a compelling risk-reward setup ahead of potentially positive readthrough from a late-stage trial run by Pfizer ( PFE ). Its bu…
LIXTE Biotechnology Holdings ( LIXT ) announced on Friday that it has agreed to acquire 100% of NOMAD Transportable Power Systems and plans to rename the company NOMAD Power Solutions after closing the deal. Management said the deal marks a transformational sh…